Skripsi

Comparison Average Prostate Specific Antigen (PSA) Levels in Prostatic Hyperplasia and Adenocarcinoma in Patients Diagnosed at Department of Anatomical Pathology, Cipto Mangunkusumo Hospital = Perbandingan antara Kadar Prostate Specfic Antigen (PSA) pada Pasien yang Didiagnosis Hiperplasia Prostat dan Adenokarsinoma Prostat di Departemen Patologi Anatomi, Rumah Sakit Cipto Mangunkusumo.

Backgound: Prostate Specific Antigen (PSA) has been widely used as screening tool for prostatic adenocarcinoma. The increased PSA level suggests this condition. However, it was later known that the level of serum PSA could also be elevated by a number of conditions. One of which is a benign condition called prostatic hyperplasia. Often, the information provided by PSA level becomes misleading. Aims: This study was conducted to compare the level of PSA in prostatic adenocarcinoma and hyperplasia cases in Department of Anatomical Pathology, Cipto Mangunkusumo Hospital. Furthermore, the purpose of this study was also to elaborate the importance of PSA as diagnostic marker Methods: This study was conducted with cross-sectional method. The source of data was obtained from request forms belonged to 53 patients diagnosed with prostatic adenocarcinoma and the other 53 patients suffer from hyperplasia. Results: In the end of the study, there was significant PSA level difference between in cases of prostatic adenocarcinoma and hyperplasia (p